Bank of New York Mellon’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.78M | Buy |
98,942
+113
| +0.1% | +$2.27K | ﹤0.01% | 2872 |
|
|
2025
Q4 | $2.31M | Buy |
98,829
+3,476
| +4% | +$75.4K | ﹤0.01% | 2748 |
|
|
2025
Q3 | $1.9M | Buy |
95,353
+1,923
| +2% | +$34.5K | ﹤0.01% | 2830 |
|
|
2025
Q2 | $1.28M | Sell |
93,430
-60
| -0.1% | -$576 | ﹤0.01% | 2986 |
|
|
2025
Q1 | $1.03M | Sell |
93,490
-507
| -0.5% | -$5.41K | ﹤0.01% | 3046 |
|
|
2024
Q4 | $1M | Buy |
93,997
+6,430
| +7% | +$77K | ﹤0.01% | 3164 |
|
|
2024
Q3 | $1.11M | Sell |
87,567
-9,052
| -9% | -$134K | ﹤0.01% | 3084 |
|
|
2024
Q2 | $1.62M | Buy |
96,619
+28,400
| +42% | +$404K | ﹤0.01% | 2914 |
|
|
2024
Q1 | $1.02M | Sell |
68,219
-1,885
| -3% | -$30.8K | ﹤0.01% | 3138 |
|
|
2023
Q4 | $1.05M | Buy |
70,104
+12,298
| +21% | +$160K | ﹤0.01% | 3160 |
|
|
2023
Q3 | $810K | Buy |
57,806
+11,886
| +26% | +$191K | ﹤0.01% | 3287 |
|
|
2023
Q2 | $475K | Buy |
+45,920
| New | +$507K | ﹤0.01% | 3626 |
|
|
2022
Q2 | – | Sell |
-67,486
| Closed | -$588K | – | 4702 |
|
|
2022
Q1 | $588K | Buy |
67,486
+7,197
| +12% | +$56.1K | ﹤0.01% | 3618 |
|
|
2021
Q4 | $573K | Sell |
60,289
-1,045
| -2% | -$14.7K | ﹤0.01% | 3716 |
|
|
2021
Q3 | $1.03M | Buy |
61,334
+5,277
| +9% | +$83.6K | ﹤0.01% | 3374 |
|
|
2021
Q2 | $856K | Buy |
56,057
+3,026
| +6% | +$54.7K | ﹤0.01% | 3512 |
|
|
2021
Q1 | $1.03M | Buy |
53,031
+1,145
| +2% | +$24.3K | ﹤0.01% | 3313 |
|
|
2020
Q4 | $935K | Sell |
51,886
-1,867
| -3% | -$39.1K | ﹤0.01% | 3284 |
|
|
2020
Q3 | $1.04M | Sell |
53,753
-1,560
| -3% | -$35.3K | ﹤0.01% | 3110 |
|
|
2020
Q2 | $1.44M | Buy |
55,313
+7,117
| +15% | +$174K | ﹤0.01% | 2882 |
|
|
2020
Q1 | $860K | Sell |
48,196
-39
| -0.1% | -$1.05K | ﹤0.01% | 3085 |
|
|
2019
Q4 | $1.61M | Buy |
48,235
+1,992
| +4% | +$54.4K | ﹤0.01% | 2954 |
|
|
2019
Q3 | $1.1M | Buy |
46,243
+1,795
| +4% | +$58.7K | ﹤0.01% | 3124 |
|
|
2019
Q2 | $1.6M | Buy |
+44,448
| New | +$1.64M | ﹤0.01% | 2931 |
|
|
2018
Q4 | – | Sell |
-8,923
| Closed | -$421K | – | 4292 |
|
|
2018
Q3 | $421K | Buy |
+8,923
| New | +$415K | ﹤0.01% | 3717 |
|
Other funds holding URGN
RI
KCM
JFG
PBA
ACA
